Skip to main content
. 2011 Apr 28;4:111–118. doi: 10.2147/JMDH.S17154

Table 3.

Selected Multidisciplinary Stroke Clinic outcomes, people with stroke or TIA

Characteristic Na First visit Last visit P-value
History
Number of BP medications at beginning of first visit, mean ± SDb 140 1.53 (± 1.14)b 1.74 (± 1.16)b <0.001
WHO DDD for BP medications at beginning of first visit, mean ± SDb 140 1.87 (± 1.98)b 2.01 (± 2.04)b 0.001
Increased exercise by last visit, yes, n (%) 36 26 (72%)
Decreased frequency of smoking by last visit, yes, n (%) 16 6 (40%)
Attempted to quit smoking by last visit, yes, n (%) 16 12 (75%)
Successful in quitting smoking by last visit, yes, n (%) 15 1 (7%)
At risk for falls, yes, n (%) 21 16 (76%) 17 (81%) 0.707
Assessments and clinical tests
Functional Independence Measure, mean ± SD 29 105.31 ± 19.98 105.76 ± 15.41 0.786
Systolic blood pressure (mm Hg), mean ± SD 58 137.21 ± 21.96 128.60 ± 19.80 0.007
Diastolic blood pressure (mm Hg), mean ± SD 58 77.88 ± 14.83 71.98 ± 10.20 0.004
Orthostasis, yes, n (%)b 24 6 (25%) 4 (17%) 0.035
Depression, impaired, n (%) 45 19 (42%) 18 (40%) 0.830
Cognition, impaired, n (%)b 45 31 (69%) 26 (58%) 0.274
NIH Stroke Severity Scale, mean ± SD 23 3.13 ± 3.24 3.00 ± 2.84 0.710
Pain, present at time of initial clinic visit 112 45 (40%)
LDL cholesterol (mg/dL), mean ± SD 33 101.91 ± 23.10 180.61 ± 24.97 0.001
Hemoglobin A1c (%), mean ± SD 19 7.08 ± 1.36 6.95 ± 1.53 0.723

Notes:

a

Sample size changed accordingly for people with more than one visit;

b

Data regarding change from blood pressure medications from first visit only.

Abbreviations: BP, blood pressure; DDD, defined daily dose; LDL, low-density lipoprotein; NIH, National Institute of Health; SD, standard deviation; TIA, transient ischemic attack; WHO, World Health Organization.